Notice of Intent to Sole Source - BR2 Bilirubin Stat-Analyzer, Total and Direct Bilirubin Kit and Preventive Maintenance

SOL #: HT941026N0031Special NoticeSole Source

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)

Place of Performance

JBPHH, HI

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Chemical Analysis Instruments (6630)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 23, 2026
2
Action Date
Mar 4, 2026, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA), Healthcare Contracting Division – West (HCD-W), has issued a Notice of Intent to Sole Source for a BR2 Bilirubin Stat-Analyzer, Total and Direct Bilirubin Kit, and 4-year Preventive Maintenance Service for the Naval Health Clinic (NHC) Hawaii, Kaneohe Bay Laboratory. The intent is to award a firm fixed-price contract to Nova Biomedical Corporation. Interested parties challenging this sole source must submit a capability statement by March 4, 2026.

Scope of Work

This requirement includes the procurement, installation, and training for a BR2 Bilirubin Stat-Analyzer and its proprietary Total and Direct Bilirubin Kit. Additionally, it covers a 4-year preventive maintenance service plan for the equipment.

Contract & Timeline

  • Type: Firm Fixed-Price Supply and Preventive Maintenance
  • Sole Source To: Nova Biomedical Corporation
  • Period of Performance:
    • Delivery: April 1, 2026 (includes first year warranty)
    • Service Option Years: April 1, 2027 – March 31, 2031 (4 years)
  • Published: February 23, 2026

Eligibility / Set-Aside

This acquisition is proposed as Other Than Full and Open competition on a sole source basis. Nova Biomedical Corporation is identified as the sole manufacturer of the BR2 Bilirubin Stat Analyzer and its proprietary kits, with no authorized third-party maintenance providers. The Government has no reasonable expectation of receiving quotes from two or more small businesses.

Submission & Evaluation

This is not a request for competitive quotes. However, sources interested in challenging the sole source determination must submit a capability statement. The statement should detail management, technical data, and cost information, clearly demonstrating the ability to provide the required equipment and maintenance. Capability statements are limited to six (8.5 x 11 inch) pages, using a font size no smaller than 10-point.

Additional Notes

  • NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing (Size Standard: 1000 employees)
  • PSC Code: 6630 - Chemical Analysis Instruments
  • Challenge Due: March 4, 2026, by 1000 Pacific Daylight Time.
  • Submission Email: denise.d.bond.civ@health.mil (Denise Bond)
  • No telephone requests or offers will be honored.

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Feb 23, 2026
Notice of Intent to Sole Source - BR2 Bilirubin Stat-Analyzer, Total and Direct Bilirubin Kit and Preventive Maintenance | GovScope